Western New York Congressman Chris Collins’ investments in an Australian biotech firm became a focus of the Senate hearings into President-elect Trump’s pick to head the Department of Health and Human Services. Democrats  pressed Congressman Tom Price about reports that he bought shares in a medical device company before he and Congressman Collins pushed legislation […]